OBJECTIVE: Heart or lung transplantation is a complex intervention requiring medication adherence. The objective of this systematic review is to estimate the prevalence of non-adherence (NA) with post-transplantation medication in heart or lung recipients and to assess its clinical impact. We examined in the selected studies if the authors considered the patient's perspective in their evaluations. METHODS: The electronic database MEDLINE, EMBASE and The Cochrane Central Register were searched. Only studies that reported the number of non-adhere subjects were eligible. The different methods of measurement, the ways in which authors defined NA and if authors had integrated patient's perspective in their secondary objectives were also assessed. RESULTS: The range frequency of NA was 1-42.9% for all drugs. Non-adherent patients tend to experience worse outcomes compared to adherent patients. The patient's perception of drug side-effects is the most reported patient-related factor for impairing adherence. CONCLUSION: NA after heart or lung transplantation is an important issue and concerns not only immunosuppressant treatments. The main striking point of the selected studies is the lack of patient perspective and the omission of patients-healthcare providers' relationship. PRACTICE IMPLICATIONS: Future research must focus on patients' motivation for the medication-taking behaviour.
OBJECTIVE: Heart or lung transplantation is a complex intervention requiring medication adherence. The objective of this systematic review is to estimate the prevalence of non-adherence (NA) with post-transplantation medication in heart or lung recipients and to assess its clinical impact. We examined in the selected studies if the authors considered the patient's perspective in their evaluations. METHODS: The electronic database MEDLINE, EMBASE and The Cochrane Central Register were searched. Only studies that reported the number of non-adhere subjects were eligible. The different methods of measurement, the ways in which authors defined NA and if authors had integrated patient's perspective in their secondary objectives were also assessed. RESULTS: The range frequency of NA was 1-42.9% for all drugs. Non-adherent patients tend to experience worse outcomes compared to adherent patients. The patient's perception of drug side-effects is the most reported patient-related factor for impairing adherence. CONCLUSION: NA after heart or lung transplantation is an important issue and concerns not only immunosuppressant treatments. The main striking point of the selected studies is the lack of patient perspective and the omission of patients-healthcare providers' relationship. PRACTICE IMPLICATIONS: Future research must focus on patients' motivation for the medication-taking behaviour.
Authors: André Nathan Costa; Elaine Marques Hojaij; Liliane Saraiva de Mello; Felipe Xavier de Melo; Priscila Cilene Leon Bueno de Camargo; Silvia Vidal Campos; Jose Eduardo Afonso Junior; Rafael Medeiros Carraro; Ricardo Henrique de Oliveira Braga Teixeira Journal: J Bras Pneumol Date: 2015 Jan-Feb Impact factor: 2.624
Authors: Hendrik Suhling; Jessica Rademacher; Imke Zinowsky; Jan Fuge; Mark Greer; Gregor Warnecke; Jacqueline M Smits; Anna Bertram; Axel Haverich; Tobias Welte; Jens Gottlieb Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Eulalia Roig; Sonia Mirabet; Mar Gomis-Pastor; Jan T De Pourcq; Irene Conejo; Anna Feliu; Vicens Brossa; Laura Lopez; Andreu Ferrero-Gregori; Anna Barata; M Antonia Mangues Journal: JMIR Mhealth Uhealth Date: 2020-02-04 Impact factor: 4.773
Authors: Regina van Zanten; Monique van Dijk; Joost van Rosmalen; Denise Beck; Robert Zietse; Ann Van Hecke; AnneLoes van Staa; Emma K Massey Journal: Trials Date: 2022-01-06 Impact factor: 2.279